Safety and Early Efficacy Results of Phase 1 Study of Affinity Tuned and Trackable AIC100 CAR T Cells in ICAM-1 Positive Relapsed And/or Refractory Advanced Poorly Differentiated and Anaplastic Thyroid Cancers.
JOURNAL OF CLINICAL ONCOLOGY（2023）
Key words
Tumor Regression,CAR T Cells
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined